Vista Pharmaceuticals Ltd — Results, 13-08-2025: Result

Vista Pharmaceuticals' Board has approved the financial results for the quarter, reporting a net loss of Rs. 1.29 Cr, widening from a Rs. 0.86 Cr loss in the same quarter last year. Revenue from operations also declined to Rs. 1.52 Cr from Rs. 1.80 Cr. The company will hold its 34th Annual General Meeting via video conference on September 30. Key agenda items include approving the re-appointment of Mr. Murali Meraga as Managing Director and Mr. Pavan Sathvik Gilaka and Mr. Dhananjaya Alli as Whole-time Directors for three-year terms, along with the re-appointment of two other directors by rotation.